Hand cooling and compression are highly effective in preventing chemotherapy-induced peripheral neuropathy, according to a ...

Adding an immune checkpoint inhibitor (ICI) to chemotherapy for advanced prostate cancer failed to improve survival as ...

Experts discuss the patient case of Janet, a 58-year-old with her 2 positive metastatic breast cancer, and after 14 months on ...

Cryotherapy is emerging as a promising strategy to prevent chemotherapy-induced peripheral neuropathy, but adoption in clinical practice remains limited.

虽然包括免疫和靶向治疗在内的创新药物越来越多地被用于癌症治疗，但化疗仍是癌症治疗的重要基石。紫杉烷类是常用化疗药物，化疗引起的周围神经病变（CIPN）是紫杉烷类常见的剂量限制性不良反应 [1] 。CIPN ...

Promising therapies for platinum-resistant ovarian cancer produced mixed results in separate trials. The AKT inhibitor ...

A real-world study showed HER2DX guided treatment changes in approximately 48% of HER2-positive breast cancer cases.

Concept: Reprogrammed intratumoral neurons recruit CAFs to suppress immune cell infiltration. Impact: Denervation may augment the efficacy of immunotherapy or taxane-based chemotherapy in pancreatic ...

Taxane chemotherapy is unable to sensitize prostate cancer to immune checkpoint inhibitors, resulting in another negative trial with immunotherapy in prostate cancer,” said Andrea Necchi, MD.

improved rPFS in the phase 3 TRITON3 trial in men with chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC), previously treated with Zytiga or Xtandi and taxane-based ...

In this randomized controlled trial, adjuvant trastuzumab emtansine (T-DM1) reduced invasive disease events in patients with ...